ESM1 and metastatic malignant neoplasm in the lymph nodes: In datasets GSE13861 and GSE66229, significantly higher levels of ESM1 transcripts were observed in GC patients with advanced clinical stages (stage 4) and lymph node metastasis (N3) compared to patients with earlier clinical and N stages (Figures 1B, S1C).